Latest Insider Transactions at Inari Medical, Inc. (NARI)
This section provides a real-time view of insider transactions for Inari Medical, Inc. (NARI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Inari Medical, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Inari Medical, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 14
2023
|
Donald B Milder Director |
SELL
Bona fide gift
|
Indirect |
200,000
-3.35%
|
-
|
|
Dec 12
2023
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,500
-1.86%
|
$403,000
$62.7 P/Share
|
|
Dec 12
2023
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+3.55%
|
$0
$0.46 P/Share
|
|
Dec 04
2023
|
William Hoffman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
103,492
+4.7%
|
$0
$0.43 P/Share
|
|
Nov 16
2023
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
37,448
-4.05%
|
$2,209,432
$59.87 P/Share
|
|
Nov 16
2023
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
25,451
-3.74%
|
$1,501,609
$59.87 P/Share
|
|
Nov 15
2023
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
25,000
-0.42%
|
$1,500,000
$60.75 P/Share
|
|
Nov 13
2023
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,500
-1.24%
|
$364,000
$56.2 P/Share
|
|
Nov 13
2023
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+3.55%
|
$0
$0.46 P/Share
|
|
Nov 08
2023
|
Donald B Milder Director |
BUY
Open market or private purchase
|
Indirect |
2,100
+0.03%
|
$109,200
$52.89 P/Share
|
|
Nov 07
2023
|
Donald B Milder Director |
BUY
Open market or private purchase
|
Indirect |
54,000
+1.75%
|
$2,862,000
$53.44 P/Share
|
|
Oct 16
2023
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
25,000
-0.31%
|
$1,400,000
$56.32 P/Share
|
|
Oct 12
2023
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,500
-0.93%
|
$364,000
$56.34 P/Share
|
|
Oct 12
2023
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+3.55%
|
$0
$0.46 P/Share
|
|
Oct 01
2023
|
William Hoffman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,018
-0.1%
|
$131,170
$65.4 P/Share
|
|
Oct 01
2023
|
Andrew Hykes President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,867
-0.2%
|
$186,355
$65.4 P/Share
|
|
Oct 01
2023
|
Hill, Mitch C. Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,572
-0.31%
|
$102,180
$65.4 P/Share
|
|
Oct 01
2023
|
Thomas Tu Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,614
-0.15%
|
$104,910
$65.4 P/Share
|
|
Sep 15
2023
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
25,000
-0.48%
|
$1,650,000
$66.85 P/Share
|
|
Sep 12
2023
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,500
-1.23%
|
$435,500
$67.55 P/Share
|
|
Sep 12
2023
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+3.52%
|
$0
$0.46 P/Share
|
|
Aug 16
2023
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
36,676
-1.83%
|
$2,420,616
$66.74 P/Share
|
|
Aug 16
2023
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
24,926
-1.71%
|
$1,645,116
$66.74 P/Share
|
|
Aug 15
2023
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
25,000
-0.39%
|
$1,725,000
$69.7 P/Share
|
|
Aug 14
2023
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,500
-0.74%
|
$455,000
$70.03 P/Share
|
|
Aug 14
2023
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+3.52%
|
$0
$0.46 P/Share
|
|
Jul 17
2023
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
25,000
-0.57%
|
$1,425,000
$57.21 P/Share
|
|
Jul 12
2023
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,500
-1.83%
|
$364,000
$56.59 P/Share
|
|
Jul 12
2023
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+3.52%
|
$0
$0.46 P/Share
|
|
Jul 01
2023
|
William Hoffman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,018
-0.09%
|
$117,044
$58.14 P/Share
|
|
Jul 01
2023
|
Hill, Mitch C. Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,572
-0.3%
|
$91,176
$58.14 P/Share
|
|
Jul 01
2023
|
Andrew Hykes President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,999
-0.13%
|
$115,942
$58.14 P/Share
|
|
Jul 01
2023
|
Thomas Tu Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,125
-0.1%
|
$65,250
$58.14 P/Share
|
|
Jun 15
2023
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
25,000
-0.56%
|
$1,450,000
$58.0 P/Share
|
|
Jun 12
2023
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,500
-1.82%
|
$383,500
$59.63 P/Share
|
|
Jun 12
2023
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+3.49%
|
$0
$0.46 P/Share
|
|
May 27
2023
|
Kirk G. Nielsen Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,982
+4.63%
|
-
|
|
May 27
2023
|
Jonathan D Root Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,982
+0.55%
|
-
|
|
May 27
2023
|
Donald B Milder Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,982
+1.16%
|
-
|
|
May 18
2023
|
Kirk G. Nielsen Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,412
+3.96%
|
-
|
|
May 18
2023
|
Cynthia L Lucchese Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,412
+6.57%
|
-
|
|
May 18
2023
|
Robert Keith Warner Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,412
+23.11%
|
-
|
|
May 18
2023
|
Catherine M. Szyman Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,412
+11.64%
|
-
|
|
May 18
2023
|
Dana G Mead Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,412
+25.57%
|
-
|
|
May 18
2023
|
Jonathan D Root Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,412
+0.45%
|
-
|
|
May 18
2023
|
William Hoffman Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,412
+0.21%
|
-
|
|
May 18
2023
|
Rebecca Chambers Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,412
+26.23%
|
-
|
|
May 18
2023
|
Donald B Milder Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,412
+0.95%
|
-
|
|
May 17
2023
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
12,751
-1.1%
|
$879,819
$69.19 P/Share
|
|
May 17
2023
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
18,760
-1.18%
|
$1,294,440
$69.19 P/Share
|